Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Garsia

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Internal Medicine Journal|June 1, 2017
Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?Avalon Moonen, Roger Garsia, Peter Youssef, et al.
Respirology Case Reports|April 13, 2022
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndromeIshith Seth, Shyam Prakaash Bhagavata Srinivasan, Gabriella Bulloch, et al.
AIDS Research and Human Retroviruses|May 6, 2017
Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, AustraliaAngie Pinto, Alex Carrera, Hanan Salem, et al.
Plos One|May 11, 2017
A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012Alison Castley, Shailendra Sawleshwarkar, Rick Varma, et al.
The Journal of Infectious Diseases|September 21, 2011
Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trialHelen Byakwaga, Mark Kelly, Damian F J Purcell, et al.
AIDS (London, England)|May 11, 2018
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latencyVanessa A Evans, Renée M van der Sluis, Ajantha Solomon, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2012
Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)Gary Y J Chew, Umang Sinha, Paul A Gatenby, et al.
Nature Medicine|February 17, 2009
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Internal Medicine Journal|June 1, 2017
Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?Avalon Moonen, Roger Garsia, Peter Youssef, et al.
Respirology Case Reports|April 13, 2022
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndromeIshith Seth, Shyam Prakaash Bhagavata Srinivasan, Gabriella Bulloch, et al.
AIDS Research and Human Retroviruses|May 6, 2017
Evolution of HIV-1 Surveillance Drug Resistance Mutations Over 10 Years in New South Wales, AustraliaAngie Pinto, Alex Carrera, Hanan Salem, et al.
Plos One|May 11, 2017
A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012Alison Castley, Shailendra Sawleshwarkar, Rick Varma, et al.
The Journal of Infectious Diseases|September 21, 2011
Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trialHelen Byakwaga, Mark Kelly, Damian F J Purcell, et al.
AIDS (London, England)|May 11, 2018
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latencyVanessa A Evans, Renée M van der Sluis, Ajantha Solomon, et al.
The Journal of Allergy and Clinical Immunology|August 4, 2012
Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22)Gary Y J Chew, Umang Sinha, Paul A Gatenby, et al.
Nature Medicine|February 17, 2009
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T Mitsuyasu, Thomas C Merigan, Andrew Carr, et al.
Pageof 2